American College of Cardiology

HIRSH et al., AHA/ACC Expert Consensus Document on Warfarin Therapy
JACC 2003;41:1633-52

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy  

Figures & Tables

Figure 1. The vitamin K cycle and its link to carboxylation of glutamic acid residues on vitamin K–dependent coagulation proteins.

Figure 2. Advantage of anticoagulation over aspirin for patients
with atrial fibrillation in 6 randomized trials: PATAF (249), SPAF II (247), AFASAK II (254), AFASAK I (241), SPAF III (124), and EAFT (246).

Table 1. Capillary Whole Blood (Point-of-Care) PT Instruments

Table 2. Studies of Patient Self-Testing and Self-Management of Anticoagulation

Table 3. Relationship Between Anticoagulation Intensity and Bleeding

Table 4. Randomized Trials in MI Comparing ASA, the Combination of ASA and Moderate- or Low-Intensity Warfarin, and High-Dose Warfarin: Efficacy

Table 5. Randomized Trials in MI Comparing ASA, the Combination of ASA and Moderate- or Low-Intensity Warfarin, and High-Dose Warfarin: Bleeding

Table 6. Risk-Benefit Assessment of Oral Anticoagulant Therapy in Patients With Coronary ArteryDisease: Meta-Analysis of 44 Trials Involving 24 115 Patients

© 2004 by the American Heart Association, Inc., and the American College of Cardiology Foundation